| Robert A Donohue Iii, MD | |
|
1262 Whitehorse Hamilton Square Rd, Ste 2b, Hamilton, NJ 08690-3711 | |
| (609) 585-9595 | |
| (609) 585-9444 |
| Full Name | Robert A Donohue Iii |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 39 Years |
| Location | 1262 Whitehorse Hamilton Square Rd, Hamilton, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659385144 | NPI | - | NPPES |
| 57451 | Other | AETNA | |
| 223486084 | Other | HMO BLUE | |
| 985408 | Other | PHS | |
| D0452274 | Other | INDEPENDENCE BCBS | |
| 1435994 | Other | UNITED HEALTHCARE | |
| 0209045000 | Other | KEYSTONE AMERIHEALTH | |
| F14593 | Other | HEALTHNET | |
| F14593 | Other | PHCS | |
| 1243732005 | Other | CIGNA | |
| ME5287 | Other | OXFORD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MA049912 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Robert Wood Johnson University Hospital At Hamilton | Hamilton, NJ | Hospital |
| Entity Name | Robert A Donohue Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831104488 PECOS PAC ID: 2062596075 Enrollment ID: O20080229000302 |
News Archive
Currently, one in five elderly patients discharged from a hospital is readmitted within a month. Seeking to address the human and substantial financial burden of revolving door hospital readmissions, the Affordable Care Act proposes a number of initiatives to improve care and health outcomes and reduce costs for the growing population of chronically ill people in the U.S. While transitional care is a central theme in these provisions, there is little information available to guide those responsible for implementing these important opportunities.
While many scientists and pharmaceutical companies are racing to develop a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, there is also an urgent need for a coronavirus disease (COVID-19) treatment. The potent virus has now spread to 210 countries and territories, affecting more than 3.04 million people. Now, a team of German scientists is working on using antibodies to prevent and treat COVID-19.
A recent study by researchers from the United Kingdom (UK) and Brazil shows how laboratory assays based on the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in oral fluids can be used as a suitable tool for population-based seroepidemiology studies in children. The paper is currently available on the medRxiv* preprint server while it undergoes peer review.
A gene that's associated with an autoimmune form of hair loss could be exploited to improve cancer immunotherapy, suggests a new mouse study by Columbia University Irving Medical Center (CUIMC) researchers.
PHT Corporation announced the general availability of the LogPad App™ System that collects compliant patient data using Apple and Android smartphones. The LogPad App gives sponsors and CROs the flexibility to deploy Phase II, III, and IV clinical studies plus post market and observational research to massive patient populations.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert A Donohue Iii, MD 1262 Whitehorse Hamilton Square Rd, Ste 2b, Hamilton, NJ 08690-3711 Ph: (609) 585-9595 | Robert A Donohue Iii, MD 1262 Whitehorse Hamilton Square Rd, Ste 2b, Hamilton, NJ 08690-3711 Ph: (609) 585-9595 |
News Archive
Currently, one in five elderly patients discharged from a hospital is readmitted within a month. Seeking to address the human and substantial financial burden of revolving door hospital readmissions, the Affordable Care Act proposes a number of initiatives to improve care and health outcomes and reduce costs for the growing population of chronically ill people in the U.S. While transitional care is a central theme in these provisions, there is little information available to guide those responsible for implementing these important opportunities.
While many scientists and pharmaceutical companies are racing to develop a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, there is also an urgent need for a coronavirus disease (COVID-19) treatment. The potent virus has now spread to 210 countries and territories, affecting more than 3.04 million people. Now, a team of German scientists is working on using antibodies to prevent and treat COVID-19.
A recent study by researchers from the United Kingdom (UK) and Brazil shows how laboratory assays based on the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in oral fluids can be used as a suitable tool for population-based seroepidemiology studies in children. The paper is currently available on the medRxiv* preprint server while it undergoes peer review.
A gene that's associated with an autoimmune form of hair loss could be exploited to improve cancer immunotherapy, suggests a new mouse study by Columbia University Irving Medical Center (CUIMC) researchers.
PHT Corporation announced the general availability of the LogPad App™ System that collects compliant patient data using Apple and Android smartphones. The LogPad App gives sponsors and CROs the flexibility to deploy Phase II, III, and IV clinical studies plus post market and observational research to massive patient populations.
› Verified 1 days ago
Dr. Gregory Edward Cox, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2 Hamilton Health Place, Bldg #2, Hamilton, NJ 08690 Phone: 609-586-0849 Fax: 609-586-7018 |